|
FAM164A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.688100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.841000E-01 |
| Normal-vs-Stage2 |
8.209600E-01 |
| Normal-vs-Stage3 |
1.827950E-02 |
| Normal-vs-Stage4 |
2.000500E-03 |
| Stage1-vs-Stage2 |
7.976800E-01 |
| Stage1-vs-Stage3 |
8.178000E-02 |
| Stage1-vs-Stage4 |
1.032350E-02 |
| Stage2-vs-Stage3 |
2.625800E-01 |
| Stage2-vs-Stage4 |
1.020820E-01 |
| Stage3-vs-Stage4 |
4.013800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.989010E-01 |
| Normal-vs-AfricanAmerican |
5.583600E-02 |
| Normal-vs-Asian |
3.900400E-01 |
| Caucasian-vs-AfricanAmerican |
3.987800E-01 |
| Caucasian-vs-Asian |
9.822000E-01 |
| AfricanAmerican-vs-Asian |
4.110200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.101600E-03 |
| Normal-vs-Female |
3.185000E-01 |
| Male-vs-Female |
2.620100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.662000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.819200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.537870E-03 |
| Normal-vs-Age(81-100Yrs) |
3.215700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.241600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.263400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.198120E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.163900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.744100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.056150E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.843550E-02 |
| Classical-VS-Follicular |
2.072200E-02 |
| Classical-VS-Other |
8.291400E-01 |
| Classical-VS-Normal |
6.455200E-01 |
| Tall-VS-Follicular |
8.148200E-01 |
| Tall-VS-Other |
6.528000E-01 |
| Tall-VS-Normal |
1.159550E-02 |
| Follicular-VS-Other |
5.900000E-01 |
| Follicular-VS-Normal |
1.413800E-02 |
| Other-VS-Normal |
8.054200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.401440E-01 |
| Normal-vs-N1 |
1.626130E-02 |
| N0-vs-N1 |
1.867630E-01 |
|
|
